We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+9.35%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$3.27B
AUM Growth
+$101M
Cap. Flow
-$114M
Cap. Flow %
-3.48%
Top 10 Hldgs %
22.11%
Holding
3,242
New
46
Increased
294
Reduced
1,814
Closed
99

Sector Composition

Rank Sector Weight
1 Technology 25.04%
2 Industrials 9.78%
3 Consumer Discretionary 9.26%
4 Financials 9.25%
5 Healthcare 6.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZYME icon
1901
Zymeworks
ZYME
$1.77B
$71.1K ﹤0.01%
4,164
-1,452
-26% -$20.8K
ELVN icon
1902
Enliven Therapeutics
ELVN
$4.25B
$70.6K ﹤0.01%
3,449
QNST icon
1903
QuinStreet
QNST
$1.19B
$70.3K ﹤0.01%
4,547
-578
-11% -$9.18K
TRML
1904
DELISTED
Tourmaline Bio
TRML
$70K ﹤0.01%
1,463
-799
-35% -$22.2K
TRVI icon
1905
Trevi Therapeutics
TRVI
$2.62B
$69.8K ﹤0.01%
7,632
+1,300
+21% +$9.75K
SYRE icon
1906
Spyre Therapeutics
SYRE
$9.05B
$69.8K ﹤0.01%
4,166
-925
-18% -$15.1K
EYPT icon
1907
EyePoint Inc
EYPT
$1.2B
$69.8K ﹤0.01%
4,902
-1,936
-28% -$22.3K
BHRB icon
1908
Burke & Herbert Financial Services Corp
BHRB
$1.48B
$69.6K ﹤0.01%
1,129
-243
-18% -$15K
PDFS icon
1909
PDF Solutions
PDFS
$2.13B
$69.6K ﹤0.01%
2,695
-350
-11% -$7.64K
AMSF icon
1910
AMERISAFE
AMSF
$515M
$69.5K ﹤0.01%
1,586
-310
-16% -$13.9K
PAHC icon
1911
Phibro Animal Health
PAHC
$1.4B
$69.1K ﹤0.01%
1,709
-360
-17% -$11.9K
SG icon
1912
Sweetgreen
SG
$725M
$69K ﹤0.01%
8,652
-1,827
-17% -$19.9K
XNCR icon
1913
Xencor
XNCR
$1.69B
$69K ﹤0.01%
5,885
-1,160
-16% -$10.1K
MDXG icon
1914
MiMedx Group
MDXG
$609M
$69K ﹤0.01%
9,887
-1,429
-13% -$9.93K
EMBC icon
1915
Embecta
EMBC
$293M
$69K ﹤0.01%
4,890
-852
-15% -$10.8K
HFWA icon
1916
Heritage Financial
HFWA
$1.22B
$68.9K ﹤0.01%
2,850
-573
-17% -$13.9K
MBIN icon
1917
Merchants Bancorp
MBIN
$2.53B
$68.9K ﹤0.01%
2,167
-482
-18% -$15.8K
FMBH icon
1918
First Mid Bancshares
FMBH
$1.39B
$68.9K ﹤0.01%
1,819
-487
-21% -$19K
ERII icon
1919
Energy Recovery
ERII
$411M
$68.7K ﹤0.01%
4,452
-1,085
-20% -$15.3K
WVE icon
1920
Wave Life Sciences
WVE
$1.04B
$68.5K ﹤0.01%
9,364
-2,080
-18% -$16.8K
FLNC icon
1921
Fluence Energy
FLNC
$2.46B
$68.5K ﹤0.01%
6,344
-1,409
-18% -$11.8K
SBSI icon
1922
Southside Bancshares
SBSI
$985M
$68.3K ﹤0.01%
2,417
-486
-17% -$14.7K
SJNK icon
1923
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.8B
$68.2K ﹤0.01%
2,665
TNDM icon
1924
Tandem Diabetes Care
TNDM
$1.57B
$67.8K ﹤0.01%
5,586
-1,284
-19% -$17.4K
BBW icon
1925
Build-A-Bear
BBW
$480M
$67.8K ﹤0.01%
1,039
-231
-18% -$13.6K

Similar funds

Ameritas Investment Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Ameritas Investment Partners held 3,242 positions worth $3.27B, up 3.2% from $3.17B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Ameritas Investment Partners withdrew a net $114M in Q3 2025, closing 99 positions and reducing 1,814 holdings. Its most notable exit was Skechers, an estimated $1.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Ameritas Investment Partners opened a new position in Capital Group Core Equity ETF worth $17.1M.

  • Ameritas Investment Partners's largest Q3 2025 buy was Capital Group Core Equity ETF: 433,015 shares worth $17.1M.
  • Ameritas Investment Partners added most to WisdomTree US Value Fund in Q3 2025, an estimated $3.63M increase.
  • Ameritas Investment Partners's biggest Q3 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $23M.
  • Ameritas Investment Partners fully exited Skechers in Q3 2025, selling an estimated $1.6M.
  • Ameritas Investment Partners's ten largest holdings make up 22% of its $3.27B portfolio in Q3 2025.
  • Ameritas Investment Partners opened 46 new positions and closed 99 in Q3 2025.
  • Ameritas Investment Partners's portfolio value rose 3.2% quarter-over-quarter to $3.27B.

Based on Ameritas Investment Partners's 13F filing for Q3 2025, filed 10 Nov 2025.